首页> 外文期刊>International Journal of Pharmaceutics >Design and in vivo evaluation of a patch delivery system for insulin based on thiolated polymers.
【24h】

Design and in vivo evaluation of a patch delivery system for insulin based on thiolated polymers.

机译:基于硫醇化聚合物的胰岛素贴剂递送系统的设计和体内评估。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

PURPOSE: The aim of this study was to develop and evaluate a novel three-layered oral delivery system for insulin in vivo. METHODS: The patch system consisted of a mucoadhesive layer, a water insoluble backing layer made of ethylcellulose and an enteric coating made of Eudragit. Drug release studies were performed in media mimicking stomach and intestinal fluids. For in vivo studies patch systems were administered orally to conscious non-diabetic rats. Orally administered insulin in aqueous solution was used as control. After the oral administration of the patch systems a decrease of glucose and increase of insulin blood levels were measured. RESULTS: The mucoadhesive layer, exhibiting a diameter of 2.5mm and a weight of 5mg, comprised polycarbophil-cysteine conjugate (49%), bovine insulin (26%), gluthatione (5%) and mannitol (20%). 74.8+/-4.8% of insulin was released from the delivery system over 6h. Six hours after administration of the patch system mean maximum decrease of blood glucose level of 31.6% of the initial value could be observed. Maximum insulin concentration in blood was 11.3+/-6.2ng/ml and was reached 6h after administration. The relative bioavailability of orally administered patch system versus subcutaneous injection was 2.2%. CONCLUSION: The results indicate that the patch system provides enhancement of intestinal absorption and thereby offers a promising strategy for peroral peptide delivery.
机译:目的:本研究的目的是开发和评估一种新颖的体内三层口服胰岛素输送系统。方法:贴剂系统由粘膜粘附层,由乙基纤维素制成的不溶于水的背衬层和由Eudragit制成的肠溶衣组成。药物释放研究是在模仿胃和肠液的培养基中进行的。为了进行体内研究,将贴剂系统口服给予有意识的非糖尿病大鼠。将口服水溶液中的胰岛素用作对照。口服施用贴剂系统后,测量到葡萄糖减少和胰岛素血液水平增加。结果:粘膜粘附层的直径为2.5mm,重量为5mg,由聚卡波非-半胱氨酸结合物(49%),牛胰岛素(26%),谷胱甘肽(5%)和甘露醇(20%)组成。在6小时内77.4 +/- 4.8%的胰岛素从输送系统中释放出来。施用贴剂系统六小时后,平均血糖水平可降低至初始值的31.6%。血液中最大胰岛素浓度为11.3 +/- 6.2ng / ml,并在给药后6小时达到。口服施用的贴剂系统与皮下注射的相对生物利用度为2.2%。结论:该结果表明,该贴剂系统提供了肠道吸收的增强,从而为口服肽的输送提供了有希望的策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号